Author Archives: Joline Lim

Rheumagen Series A Financing Hla Gene Editing Therapies 2024 1

BIOTECH

RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases
January 9, 2025

Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401,...

Read more
Napo Therapeutics Best Pharmaceuticals Innovator Europe 2024

BIOTECH

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year – Europe”
November 19, 2024

Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar’s novel oral plant-based...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept